Product Description
Overall, the global intravascular lithotripsy (IVL) market was valued at $193 million in 2023. This is expected to increase over the forecast period at a CAGR of 9.3% to reach $359 million.
Throughout this medical market research, we analyzed the IVL market across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, market values, and to create accurate forecasts. The full report suite on the global market for IVL extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global IVL Market Insights
A current trend in the global IVL market is the rising use of this innovative technology to treat complicated calcified coronary artery issues. IVL provides a safe and effective way to handle challenging calcifications. The technique’s capacity to alter calcified lesions with minimal vessel trauma has gained popularity among interventional cardiologists, making it a valuable tool in percutaneous coronary interventions. This trend is driven by the increasing acknowledgment of IVL’s potential to enhance procedural outcomes and improve patient care, especially in cases with severely calcified arteries
Global IVL Market Share Insights
Shockwave Medical is the exclusive player in this market, with its Peripheral Lithoplasty® gaining FDA approval for peripheral use in 2016. The company’s revenue comes mainly from the U.S., and it has conducted trials such as DISRUPT II, III, and below the knee (BTK) to confirm its effectiveness. This innovative technology addresses limitations by improving the treatment of calcified plaques. Genesis MedTech, partnering with Shockwave, is seeking NMPA approval in China for the Shockwave IVL System to enhance localized manufacturing and distribution.
Market Segmentation Summary
- IVL Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
